Frontiers in Oncology | Breast Cancer

Original Research

Published on 01 Dec 2022

Contrast-enhanced ultrasonography for early prediction of response of neoadjuvant chemotherapy in breast cancer

in Breast Cancer

Jiabao Guo
Bao-Hua Wang
Mengna He
Peifen Fu
Minya Yao
Tian’an Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.1026647

2,752 views
7 citations

Original Research

Published on 01 Dec 2022

CDK4/6 inhibitor resistance: A bibliometric analysis

in Breast Cancer

Jiayuecheng Pang
Hengyu Li
Yuan Sheng

Frontiers in Oncology

doi 10.3389/fonc.2022.917707

5,542 views
6 citations

Original Research

Published on 01 Dec 2022

Expression analysis of cytokines IL-5, IL-6, IL-8, IL-17 and VEGF in breast cancer patients

in Breast Cancer

Gang Liu
Xiang-Ting Chen
Hao Zhang
Xin Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.1019247

3,783 views
13 citations

Original Research

Published on 01 Dec 2022

Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy

in Breast Cancer

Angela Toss
Marta Venturelli
Monica Civallero
Claudia Piombino
Federica Domati
Guido Ficarra
Francesca Combi
Eleonora Cabitza
Federica Caggia
Elena Barbieri

Frontiers in Oncology

doi 10.3389/fonc.2022.1016295

11,592 views
11 citations

Systematic Review

Published on 30 Nov 2022

Prognostic value of epithelial–mesenchymal transition circulating tumor cells in female breast cancer: A meta-analysis

in Breast Cancer

Qiang Zhao
Bingbing Li
Qi Gao
Yang Luo
Liang Ming

Frontiers in Oncology

doi 10.3389/fonc.2022.1024783

2,177 views
4 citations

Original Research

Published on 30 Nov 2022

Expression patterns and prognostic implications of tumor-infiltrating lymphocytes dynamics in early breast cancer patients receiving neoadjuvant therapy: A systematic review and meta-analysis

in Breast Cancer

Yajing Zhu
Evangelos Tzoras
Alexios Matikas
Jonas Bergh
Antonios Valachis
Ioannis Zerdes
Theodoros Foukakis

Frontiers in Oncology

doi 10.3389/fonc.2022.999843

3,382 views
12 citations

Original Research

Published on 30 Nov 2022

PDLIM2 is highly expressed in Breast Cancer tumour-associated macrophages and is required for M2 macrophage polarization

in Breast Cancer

Orla T. Cox
Neil O’Sullivan
Emilie Tresse
Stephanie Ward
Niamh Buckley
Rosemary O’Connor

Frontiers in Oncology

doi 10.3389/fonc.2022.1028959

2,991 views
2 citations

Case Report

Published on 30 Nov 2022

Abemaciclib plus fulvestrant for the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer with cystic brain metastases: A case report and literature review

in Breast Cancer

Zhaohui Chu

Frontiers in Oncology

doi 10.3389/fonc.2022.984454

3,389 views
3 citations

Original Research

Published on 30 Nov 2022

Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation

in Breast Cancer

Arianna Scagliotti
Laura Capizzi
Marina Elena Cazzaniga
Alice Ilari
Marco De Giorgi
Nicoletta Cordani
Matteo Gallazzi
Antonino Bruno
Giuseppe Pelosi
Adriana Albini

Frontiers in Oncology

doi 10.3389/fonc.2022.998274

5,055 views
7 citations

Systematic Review

Published on 28 Nov 2022

Diagnostic performance of radiomics in predicting axillary lymph node metastasis in breast cancer: A systematic review and meta-analysis

in Breast Cancer

Xiuru Gong
Yaxin Guo
Tingting Zhu
Xiaolin Peng
Dongwei Xing
Minguang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1046005

5,302 views
28 citations

Case Report

Published on 28 Nov 2022

Adolescent triple-negative breast cancer with germline pathogenic variants in both BRCA1 and TP53 genes: A case report

in Breast Cancer

Dongmei Chen
Chenyang Zhang
Mengqi Yuan
Ying Zhang
Qing Liu
Donggui Wan

Frontiers in Oncology

doi 10.3389/fonc.2022.970641

2,372 views
2 citations

Original Research

Published on 28 Nov 2022

Development of a breast cancer case management information platform (BC-CMIP) module based on patient-perceived value

in Breast Cancer

Yinyin Liang
Yan Gao
Guobing Yin
Wenjun Chen
Xiuni Gan

Frontiers in Oncology

doi 10.3389/fonc.2022.1034171

3,882 views
1 citation

Original Research

Published on 25 Nov 2022

Construction and validation of a prognostic nomogram in metastatic breast cancer patients of childbearing age: A study based on the SEER database and a Chinese cohort

in Breast Cancer

Xiang Ma
Yapeng Xing
Zeying Li
Shun Qiu
Wenzhao Wu
Jinfeng Bai

Frontiers in Oncology

doi 10.3389/fonc.2022.999873

2,460 views
3 citations

Original Research

Published on 25 Nov 2022

Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer

in Breast Cancer

Shuqian Feng
Jiandong Yin

Frontiers in Oncology

doi 10.3389/fonc.2022.847880

3,338 views
13 citations

Original Research

Published on 24 Nov 2022

Assessing chemotherapy dosing strategies in a spatial cell culture model

in Breast Cancer

Dhruba Deb
Shu Zhu
Michael J. LeBlanc
Tal Danino

Frontiers in Oncology

doi 10.3389/fonc.2022.980770

2,638 views
2 citations

Review

Published on 24 Nov 2022

Understanding and harnessing triple-negative breast cancer-related microbiota in oncology

in Breast Cancer

Ciaran Devoy
Yensi Flores Bueso
Mark Tangney

Frontiers in Oncology

doi 10.3389/fonc.2022.1020121

10,126 views
20 citations